224 related articles for article (PubMed ID: 23189617)
1. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
Zhu YK; Cheng N; Hu Y; Cen YZ
Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.
Shi M; Du L; Liu D; Qian L; Hu M; Yu M; Yang Z; Zhao M; Chen C; Guo L; Wang L; Song L; Ma Y; Guo N
J Pathol; 2012 Oct; 228(2):148-57. PubMed ID: 22287315
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
4. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
Peta E; Cappellesso R; Masi G; Sinigaglia A; Trevisan M; Grassi A; Di Camillo B; Vassarotto E; Fassina A; Palù G; Barzon L
Hum Pathol; 2017 Mar; 61():33-40. PubMed ID: 27818285
[TBL] [Abstract][Full Text] [Related]
6. Unique microRNA expression profiles in cervical cancer.
Gocze K; Gombos K; Juhasz K; Kovacs K; Kajtar B; Benczik M; Gocze P; Patczai B; Arany I; Ember I
Anticancer Res; 2013 Jun; 33(6):2561-7. PubMed ID: 23749909
[TBL] [Abstract][Full Text] [Related]
7. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract][Full Text] [Related]
8. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
[TBL] [Abstract][Full Text] [Related]
9. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
[TBL] [Abstract][Full Text] [Related]
10. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
11. miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.
Gao D; Zhang Y; Zhu M; Liu S; Wang X
PLoS One; 2016; 11(10):e0164701. PubMed ID: 27764149
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
[TBL] [Abstract][Full Text] [Related]
13. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
14. Activation of miR-9 by human papillomavirus in cervical cancer.
Liu W; Gao G; Hu X; Wang Y; Schwarz JK; Chen JJ; Grigsby PW; Wang X
Oncotarget; 2014 Nov; 5(22):11620-30. PubMed ID: 25344913
[TBL] [Abstract][Full Text] [Related]
15. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
[TBL] [Abstract][Full Text] [Related]
16. miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells.
Singh G; Sharma SK; Singh SK
BMC Cancer; 2022 Jul; 22(1):777. PubMed ID: 35840896
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.
Yang Y; Xie YJ; Xu Q; Chen JX; Shan NC; Zhang Y
Gynecol Oncol; 2015 Sep; 138(3):683-8. PubMed ID: 26074491
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus 16 E6 modulates the expression of host microRNAs in cervical cancer.
Ben W; Yang Y; Yuan J; Sun J; Huang M; Zhang D; Zheng J
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):364-70. PubMed ID: 26384051
[TBL] [Abstract][Full Text] [Related]
19. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V
Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061
[TBL] [Abstract][Full Text] [Related]
20. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
